# EASTGATE BIOTECH CORP

EASTGATE BIOTECH CORP is a company headquartered in Salt Lake City, UT, United States.

## Company overview

- **Legal name:** EASTGATE BIOTECH CORP
- **Former names in filing history:** EASTGATE ACQUISITIONS CORP (1999-11-29 to 2015-01-21)
- **Classification:** Company
- **Industry (SIC):** 6799 — Investors, NEC
- **Headquarters:** Salt Lake City, UT, United States
- **Incorporated in:** NV
- **Fiscal year end:** December 31
- **SEC CIK:** 0001099574

## About

EASTGATE BIOTECH CORP is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001099574, and its reported industry is Investors, NEC. In 10-K filed on 2018-03-01, it reported net income of USD -2,977,471; total assets of USD 0 for the fiscal period ended 2016-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2016 (period ended 2016-12-31)

- **Net income:** -$3.0M (USD -2,977,471)
- **Total assets:** $0 (USD 0)
- **Cash and equivalents:** $0 (USD 0)

### FY2015 (period ended 2015-12-31)

- **Net income:** -$4.3M (USD -4,281,310)
- **Total assets:** $297,919 (USD 297,919)
- **Cash and equivalents:** $19,241 (USD 19,241)

### FY2014 (period ended 2014-12-31)

- **Net income:** -$4.9M (USD -4,907,686)
- **Total assets:** $482,935 (USD 482,935)
- **Cash and equivalents:** $286,481 (USD 286,481)

### FY2013 (period ended 2013-12-31)

- **Net income:** -$1.7M (USD -1,720,316)
- **Total assets:** $71,755 (USD 71,755)
- **Cash and equivalents:** $458 (USD 458)
- **Operating cash flow:** -$407,675 (USD -407,675)

## Recent SEC filings

- Form 8-K — filed 2019-09-16 — period 2019-09-04 — 8K EASTGATE BIOTECH - 09.04.19
- Form 10-Q — filed 2019-03-04 — period 2017-09-30 — CONVERTED BY EDGARWIZ
- Form 10-Q — filed 2018-12-18 — period 2017-06-30 — EASTGAT BIOTECH - 10Q -JUNE 30, 2017 - Q2
- Form 10-Q — filed 2018-08-17 — period 2017-03-31 — FORM 10Q - 03/31/17 - EASTLAND BIOTECHNOLOGY CORP.
- Form 8-K — filed 2018-06-08 — period 2018-06-01 — 8K - EASTGATE - CHANGE IN AUDITOR - 06.01.18
- Form 8-K — filed 2018-05-07 — period 2012-04-20 — 8-K EASTGATE MAY 4, 2018
- Form 10-K — filed 2018-03-01 — period 2016-12-31 — FORM 10-K
- Form 8-K — filed 2017-05-22 — period 2017-05-19 — FORM 8-K
- Form 8-K — filed 2017-05-16 — period 2017-05-12 — FORM 8-K
- Form 8-K — filed 2017-05-01 — period 2017-04-28 — FORM 8-K
- Form 10-Q — filed 2017-03-15 — period 2016-09-30 — FORM 10-Q
- Form 10-Q — filed 2017-03-09 — period 2016-06-30 — FORM 10-Q

---

Updated: 2026-10-23T20:08:00Z

Canonical page: https://altss.com/profile/eastgate-biotech-corp

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology